B. Gigic

B. Gigic is a Researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, working within the Faculty of Medicine and the Division of Preventive Oncology. Their research primarily focuses on colorectal cancer epidemiology and biomarker discovery.

Gigic's research interests span multiple areas of cancer research with particular emphasis on Colorectal Cancer, Cancer Epidemiology, Biomarkers, Physical Activity and Cancer, Nutrition and Cancer, and Cancer Survivorship. Their work often involves large cohort studies, particularly the ColoCare Study, examining how lifestyle factors, metabolic markers, and molecular pathways influence cancer outcomes.

Analysis of Gigic's publications from 2021-2025 reveals a consistent focus on identifying biomarkers that predict cancer outcomes, with particular attention to the interplay between physical activity, nutrition, and cancer progression. Much of their work examines how metabolic pathways (like the tryptophan-kynurenine pathway), inflammatory markers, and gut microbiome composition relate to colorectal cancer prognosis and survivorship.

Gigic has collaborated extensively with researchers across multiple institutions on studies examining various aspects of colorectal cancer, with a particular focus on stage I-III disease. Their work often involves complex analyses of biomarker data in relation to clinical outcomes.